SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-6.16%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$605M
AUM Growth
+$605M
(-8.3%)
Cap. Flow
-$4.4M
Cap. Flow
% of AUM
-0.73%
Top 10 Holdings %
Top 10 Hldgs %
49.83%
Holding
105
New
20
Increased
23
Reduced
13
Closed
26
Top Buys
| 1 |
Sanofi
SNY
|
$32.4M |
| 2 |
Novo Nordisk
NVO
|
$23.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$15.3M |
| 4 |
Gilead Sciences
GILD
|
$13M |
| 5 |
PTC Therapeutics
PTCT
|
$10.5M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$31.8M |
| 2 |
GSK
GSK
|
$20M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.8M |
| 4 |
Verint Systems
VRNT
|
$12.8M |
| 5 |
BLUE
bluebird bio
BLUE
|
$9.54M |
Sector Composition
| 1 | Healthcare | 79.34% |
| 2 | Technology | 12.65% |
| 3 | Industrials | 2.41% |
| 4 | Consumer Discretionary | 1.28% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Palo Alto Networks
PANW
$128B
| $6.72M | 1.04% |
32,976
+5,000
| +18% | +$1.02M |
|
|
SWTX
27
DELISTED
SpringWorks Therapeutics
SWTX
| $6.72M | 1.04% |
+310,000
| New | +$6.72M |
|
28
Exicure
XCUR
$32.4M
| $6.67M | 1.03% |
+2,637,988
| New | +$6.67M |
|
|
FSCT
29
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $6.59M | 1.02% |
173,696
+850
| +0.5% | +$32.2K |
|
30
AudioCodes
AUDC
$267M
| $6.21M | 0.96% |
328,263
-127,959
| -28% | -$2.42M |
|
31
Minerva Neurosciences
NERV
$16.8M
| $5.91M | 0.91% |
762,018
+10,000
| +1% | +$77.5K |
|
|
NEOS
32
DELISTED
Neos Therapeutics, Inc
NEOS
| $5.78M | 0.89% |
3,908,265
+196,811
| +5% | +$291K |
|
|
33
Verint Systems
VRNT
$1.23B
| $5.75M | 0.89% |
134,489
-298,063
| -69% | -$12.8M |
|
34
Aldeyra Therapeutics
ALDX
$350M
| $5.63M | 0.87% |
1,069,089
| – | – |
|
35
SolarEdge
SEDG
$1.97B
| $5.36M | 0.83% |
64,002
-108,760
| -63% | -$9.1M |
|
36
Allot
ALLT
$388M
| $5.33M | 0.82% |
661,031
| – | – |
|
37
ProQR Therapeutics
PRQR
$256M
| $5.27M | 0.81% |
915,000
+445,000
| +95% | +$2.56M |
|
|
HARP
38
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $5.11M | 0.79% |
374,031
| – | – |
|
|
RETA
39
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.08M | 0.78% |
63,269
-49,500
| -44% | -$3.97M |
|
40
Y-mAbs Therapeutics
YMAB
$390M
| $4.95M | 0.76% |
190,000
| – | – |
|
|
CHMA
41
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $4.9M | 0.76% |
+990,000
| New | +$4.9M |
|
42
Arvinas
ARVN
$580M
| $4.42M | 0.68% |
205,281
| – | – |
|
43
argenx
ARGX
$44.2B
| $4.4M | 0.68% |
38,581
| – | – |
|
|
SIOX
44
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $4.32M | 0.67% |
668,541
| – | – |
|
45
WIX.com
WIX
$8.05B
| $4.31M | 0.67% |
36,890
+16,200
| +78% | +$1.89M |
|
46
Zymeworks
ZYME
$1.07B
| $4.22M | 0.65% |
+170,000
| New | +$4.22M |
|
47
Krystal Biotech
KRYS
$4.35B
| $4.09M | 0.63% |
117,625
| – | – |
|
48
Kornit Digital
KRNT
$648M
| $4.05M | 0.63% |
131,588
-49,686
| -27% | -$1.53M |
|
49
Burlington
BURL
$18.5B
| $3.9M | 0.6% |
19,500
| – | – |
|
50
Sutro Biopharma
STRO
$85.6M
| $3.84M | 0.59% |
422,589
-23,300
| -5% | -$212K |
|